Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy

Phuong K. Morrow, Gerburg M. Wulf, Joe Ensor, Daniel J. Booser, Julia A. Moore, Peter R. Flores, Yan Xiong, Siyuan Zhang, Ian E. Krop, Eric P. Winer, David W. Kindelberger, Jeanna Coviello, Aysegul A. Sahin, Rodolfo Nuñez, Gabriel N. Hortobagyi, Dihua Yu, Francisco J. Esteva

Research output: Contribution to journal › Article › peer-review

191 Scopus citations

Sort by
Weight
Alphabetically

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy

Fingerprint

Medicine & Life Sciences